C9034 – Injection, dexamethasone 9%, intraocular, 1 mcg
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9034
- Long description
- Injection, dexamethasone 9%, intraocular, 1 mcg
- Short description
- Injection, dexamethasone 9%
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- J1095
- Added
- October 1, 2018
- Last change
- January 1, 2019 – No change
- Termination date
- December 31, 2018
Frequently asked questions
What is HCPCS code C9034?
C9034 is a HCPCS Level II code for injection, dexamethasone 9%, intraocular, 1 mcg. It was discontinued on December 31, 2018.
Does Medicare cover C9034?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9026 – Injection, vedolizumab, 1 mg
- C9027 – Injection, pembrolizumab, 1 mg
- C9028 – Injection, inotuzumab ozogamicin, 0.1 mg
- C9029 – Injection, guselkumab, 1 mg
- C9030 – Injection, copanlisib, 1 mg
- C9031 – Lutetium lu 177, dotatate, therapeutic, 1 mci
- C9032 – Injection, voretigene neparvovec-rzyl, 1 billion vector genome
- C9033 – Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- C9035 – Injection, aripiprazole lauroxil (aristada initio), 1 mg
- C9036 – Injection, patisiran, 0.1 mg
- C9037 – Injection, risperidone (perseris), 0.5 mg
- C9038 – Injection, mogamulizumab-kpkc, 1 mg
- C9039 – Injection, plazomicin, 5 mg
- C9040 – Injection, fremanezumab-vfrm, 1mg
- C9041 – Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
- C9042 – Injection, bendamustine hcl (belrapzo), 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.